NCT03066648 2025-05-18Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDSNovartisPhase 1 Completed241 enrolled
NCT01861002 2021-06-09A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AMLTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Completed15 enrolled 10 charts